SUPPRESSION BY HUMAN RECOMBINANT GAMMA INTERFERON OF INVITRO MACROPHAGE NONOPSONIC AND OPSONIC PHAGOCYTOSIS AND KILLING

被引:29
作者
SPEERT, DP
THORSON, L
机构
[1] UNIV BRITISH COLUMBIA,DEPT PEDIAT,VANCOUVER V6T 1W5,BC,CANADA
[2] UNIV BRITISH COLUMBIA,DEPT MICROBIOL,VANCOUVER V6T 1W5,BC,CANADA
关键词
D O I
10.1128/IAI.59.6.1893-1898.1991
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Although gamma interferon (IFN-gamma) exerts profound effects on the state of activation of macrophages, its influence on receptor-mediated phagocytosis and killing of extracellular bacteria is poorly understood. Human monocytes cultured in the presence of human recombinant IFN-gamma exhibited an enhanced capacity to produce superoxide anion. Although these cells bound greater numbers of particles via Fc receptors, their capacity to phagocytose by these receptors or to bind or ingest particles via receptors for C3bi, mannose, or unopsonized Pseudomonas aeruginosa was substantially depressed in a dose-dependent fashion (0.1 to 1,000 U of IFN-gamma per ml). Macrophage phagocytosis of P. aeruginosa and Staphylococcus aureus opsonized with whole serum or with serum deficient in immunoglobulin or complement was also depressed. Macrophages cultured in the presence of IFN-gamma had a diminished capacity to kill both unopsonized and opsonized P. aeruginosa. We conclude that IFN-gamma inhibits macrophage nonopsonic and opsonic receptor-mediated phagocytosis and killing but enhances oxidative radical generation; its production may exacerbate host tissue damage during chronic infection with extracellular pathogens.
引用
收藏
页码:1893 / 1898
页数:6
相关论文
共 30 条
[1]   TREATMENT OF VISCERAL LEISHMANIASIS WITH PENTAVALENT ANTIMONY AND INTERFERON-GAMMA [J].
BADARO, R ;
FALCOFF, E ;
BADARO, FS ;
CARVALHO, EM ;
PEDRALSAMPAIO, D ;
BARRAL, A ;
CARVALHO, JS ;
BARRALNETTO, M ;
BRANDELY, M ;
SILVA, L ;
BINA, JC ;
TEIXEIRA, R ;
FALCOFF, R ;
ROCHA, H ;
HO, JL ;
JOHNSON, WD .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 322 (01) :16-21
[2]  
BASHAM TY, 1983, J IMMUNOL, V130, P1492
[3]  
BECKER S, 1984, J IMMUNOL, V132, P1249
[5]  
DOUVAS GS, 1985, INFECT IMMUN, V50, P1
[6]  
EDWARDS SW, 1988, J GEN MICROBIOL, V134, P37
[7]   RECOMBINANT INTERFERON GAMMA AUGMENTS PHAGOCYTE SUPEROXIDE PRODUCTION AND X-CHRONIC GRANULOMATOUS-DISEASE GENE-EXPRESSION IN X-LINKED VARIANT CHRONIC GRANULOMATOUS-DISEASE [J].
EZEKOWITZ, RAB ;
ORKIN, SH ;
NEWBURGER, PE .
JOURNAL OF CLINICAL INVESTIGATION, 1987, 80 (04) :1009-1016
[8]   PARTIAL CORRECTION OF THE PHAGOCYTE DEFECT IN PATIENTS WITH X-LINKED CHRONIC GRANULOMATOUS-DISEASE BY SUBCUTANEOUS INTERFERON-GAMMA [J].
EZEKOWITZ, RAB ;
DINAUER, MC ;
JAFFE, HS ;
ORKIN, SH ;
NEWBURGER, PE .
NEW ENGLAND JOURNAL OF MEDICINE, 1988, 319 (03) :146-151
[9]   REGULATION OF MACROPHAGE FUNCTION BY INTERFERON-GAMMA - SOMATIC-CELL GENETIC APPROACHES IN MURINE MACROPHAGE CELL-LINES TO MECHANISMS OF GROWTH-INHIBITION, THE OXIDATIVE BURST, AND EXPRESSION OF THE CHRONIC GRANULOMATOUS-DISEASE GENE [J].
GOLDBERG, M ;
BELKOWSKI, LS ;
BLOOM, BR .
JOURNAL OF CLINICAL INVESTIGATION, 1990, 85 (02) :563-569
[10]   RECOMBINANT IMMUNE INTERFERON INCREASES IMMUNOGLOBULIN-G FC-RECEPTORS ON CULTURED HUMAN MONONUCLEAR PHAGOCYTES [J].
GUYRE, PM ;
MORGANELLI, PM ;
MILLER, R .
JOURNAL OF CLINICAL INVESTIGATION, 1983, 72 (01) :393-397